journal cover

Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis

Respiratory Research

Mar 1, 2018

Youhei TakahashiHiroki Takahashi

Abstract

Idiopathic pulmonary fibrosis (IPF) is the most frequent and severe form of idiopathic interstitial pneumonias. Although IPF has not been thought to be associated with bacterial communities, recent papers reported the possible role of microbiome composition in IPF. The roles of microbio...read more

Mentioned in this Paper

Biological Markers
Study
SFTPD gene
SFTPD
Surfactant Protein D Measurement
Lung
Environment
DNA, Ribosomal
Pulmonary Fibrosis
Vital Capacity Test
5
50
Paper Details
References
  • References28
  • Citations
123
  • References28
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

CFTR Mutant Structural Therapy

Over 1700 different mutations in the CFTR genes have been shown to cause cystic fibrosis. Here is the latest research on structural therapy for CFTR mutants.

Lung Fibrosis & Scleroderma

Scleroderma is a chronic autoimmune disease that leads to hardening of connective tissues in the body. Lung fibrosis and disease is one of the leading causes of deaths in patients with scleroderma. Here is the latest research.

American Thoracic Society: Clinical Problems

This feed has been developed in conjunction with the American Thoracic Society for the benefit of its Clinical Problems Assembly. It highlights new and impactful papers on clinical therapeutics, diagnoses, and practices pertaining to respiratory disease.

© 2020 Meta ULC. All rights reserved

Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis

Respiratory Research

Mar 1, 2018

Youhei TakahashiHiroki Takahashi

PMID: 29486761

DOI: 10.1186/s12931-018-0736-9

Abstract

Idiopathic pulmonary fibrosis (IPF) is the most frequent and severe form of idiopathic interstitial pneumonias. Although IPF has not been thought to be associated with bacterial communities, recent papers reported the possible role of microbiome composition in IPF. The roles of microbio...read more

Mentioned in this Paper

Biological Markers
Study
SFTPD gene
SFTPD
Surfactant Protein D Measurement
Lung
Environment
DNA, Ribosomal
Pulmonary Fibrosis
Vital Capacity Test
5
50

Similar Papers Found In These Feeds

CFTR Mutant Structural Therapy

Over 1700 different mutations in the CFTR genes have been shown to cause cystic fibrosis. Here is the latest research on structural therapy for CFTR mutants.

Lung Fibrosis & Scleroderma

Scleroderma is a chronic autoimmune disease that leads to hardening of connective tissues in the body. Lung fibrosis and disease is one of the leading causes of deaths in patients with scleroderma. Here is the latest research.

Related Papers

Paper Details
References
  • References28
  • Citations
123
  • References28
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/impaired-diversity-of-the-lung-microbiome/29486761